Bio Green Med Solution (BGMS) Net Cash Flow Growth (5y) (2015 - 2026)
Powered by 
Analysis
Bio Green Med Solution (BGMS) Net Cash Flow Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.56 Bn | 133.71 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 87.63 Bn | 79.64 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.65 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 60.24 Bn | 55.10 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.13 Bn | 44.13 Bn | - |
| 6 | BeOne Medicines | 40.46 Bn | 35.36 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.86 Bn | 32.56 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.00 Bn | 27.16 Bn | - |
| 9 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn |
| 10 | Bio Green Med Solution | 4.68 Mn | 886,595.10 | 79,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.00% |
| Mar 31, 2026 | -15.01% |
| Dec 31, 2025 | -15.20% |
| Sep 30, 2025 | 27.81% |
| Jun 30, 2025 | -45.03% |
| Mar 31, 2025 | 16.43% |
| Dec 31, 2024 | 17.31% |
| Sep 30, 2024 | -8.17% |
| Jun 30, 2024 | 25.96% |
| Mar 31, 2024 | -27.79% |
| Dec 31, 2023 | -14.77% |
| Sep 30, 2023 | -39.44% |
| Jun 30, 2023 | 6.16% |
| Mar 31, 2023 | -25.62% |
| Dec 31, 2022 | -19.84% |
| Sep 30, 2022 | -19.52% |
| Jun 30, 2022 | -21.17% |
| Mar 31, 2022 | -12.58% |
| Dec 31, 2021 | -20.54% |
| Sep 30, 2021 | -29.13% |